Mark Schneyer is our Executive Vice President, Chief Financial Officer, and he has been with Acadia since May 2020.
Prior to his promotion to CFO in December 2021, he served as Senior Vice President, Business Development, Chief Business Officer and Interim Chief Financial Officer.
Mr. Schneyer joined us from Pfizer Inc. where he most recently was Vice President, Business Development, for the Upjohn Division. Mr. Schneyer joined Pfizer’s Worldwide Business Development organization in 2011 and served in various business development positions of increasing responsibility. While at Pfizer, he led multiple strategic transactions, including licensing agreements, product acquisitions and divestitures, strategic collaborations, and company acquisitions.
Prior to Pfizer, he was an investment banker at Lazard and advised boards of directors and senior management teams in the healthcare sector. Mr. Schneyer earned a Bachelor of Science in Economics with a Concentration in Finance from the Wharton School of Business at the University of Pennsylvania.
